{
  "symbol": "JNJ",
  "date": "2025-10-05",
  "headlines": [
    {
      "date": "2025-10-04",
      "time": "17:01",
      "title": "Jim Cramer Believes Lawsuits Are No Longer a Major Threat to Johnson & Johnson\n\n\n(Insider Monkey)",
      "link": "/news/183879/jim-cramer-believes-lawsuits-are-no-longer-a-major-threat-to-johnson-johnson"
    },
    {
      "date": "2025-10-03",
      "time": "17:45",
      "title": "Johnson & Johnson (JNJ) Rises Higher Than Market: Key Facts\n\n\n(Zacks)",
      "link": "/news/183734/johnson-johnson-jnj-rises-higher-than-market-key-facts"
    },
    {
      "date": "2025-10-05",
      "time": "05:10PM",
      "title": "Stocks to Watch Recap: Apple, Applied Materials, Chevron, Broadcom\n\n\n(The Wall Street Journal)",
      "link": "https://finance.yahoo.com/m/e31071a5-6558-318b-9e5a-20b6601034fa/stocks-to-watch-recap%3A-apple%2C.html"
    },
    {
      "date": "2025-10-05",
      "time": "08:03AM",
      "title": "How BeOne Medicines, An IBD 50 Stock, Is Taking On Big Names In Cancer Treatment\n\n\n(Investor's Business Daily)",
      "link": "https://www.investors.com/research/the-new-america/beone-medicines-beigene-cancer-treatment?mod=IBD_FV"
    },
    {
      "date": "2025-10-05",
      "time": "03:17PM",
      "title": "Johnson & Johnson Stock Climbs As Wells Fargo Boosts Rating And Price Target\n\n\n(GuruFocus.com)",
      "link": "https://finance.yahoo.com/news/johnson-johnson-stock-climbs-wells-191731517.html"
    },
    {
      "date": "2025-10-05",
      "time": "02:07PM",
      "title": "Dow touches above 47,000, while J&J stock receives upgrade\n\n\n(Yahoo Finance Video)",
      "link": "https://finance.yahoo.com/video/dow-touches-above-47-000-180702234.html"
    },
    {
      "date": "2025-10-05",
      "time": "01:04PM",
      "title": "Stocks to Watch Friday: Apple, Applied Materials, Chevron, Broadcom\n\n\n(The Wall Street Journal)",
      "link": "https://finance.yahoo.com/m/e31071a5-6558-318b-9e5a-20b6601034fa/stocks-to-watch-friday%3A.html"
    },
    {
      "date": "2025-10-05",
      "time": "10:16AM",
      "title": "Wells Fargo sees room to run for Johnson & Johnson, highlights pharma upside\n\n\n(Investing.com)",
      "link": "https://finance.yahoo.com/news/wells-fargo-sees-room-run-141624135.html"
    },
    {
      "date": "2025-10-05",
      "time": "09:42AM",
      "title": "Apple downgraded, Alibaba upgraded: Wall Street's top analyst calls\n\n\n(The Fly)",
      "link": "https://finance.yahoo.com/news/apple-downgraded-alibaba-upgraded-wall-134258510.html"
    },
    {
      "date": "2025-10-05",
      "time": "06:27AM",
      "title": "Barclays Maintains a Hold Rating on Johnson & Johnson (JNJ) With a $176 PT\n\n\n(Insider Monkey)",
      "link": "/news/183082/barclays-maintains-a-hold-rating-on-johnson-johnson-jnj-with-a-176-pt"
    },
    {
      "date": "2025-10-02",
      "time": "14:31",
      "title": "Elon Musk Becomes First Person Worth $500 Billion, Tesla CEO's Wealth Is Now Larger Than Palantir, Alibaba\n\n\n(Benzinga)",
      "link": "https://finance.yahoo.com/news/elon-musk-becomes-first-person-183110846.html"
    },
    {
      "date": "2025-10-05",
      "time": "07:06AM",
      "title": "Boston Scientific aims for market leadership in electrophysiology\n\n\n(MedTech Dive)",
      "link": "https://finance.yahoo.com/m/50cb16bf-218b-3a28-9eac-886e2042f9b5/boston-scientific-aims-for.html"
    },
    {
      "date": "2025-10-05",
      "time": "03:08AM",
      "title": "Johnson & Johnson (JNJ) Is Leading The Industry In Cancer Treatments, Says Jim Cramer\n\n\n(Insider Monkey)",
      "link": "/news/181862/johnson-johnson-jnj-is-leading-the-industry-in-cancer-treatments-says-jim-cramer"
    },
    {
      "date": "2025-10-05",
      "time": "02:55AM",
      "title": "Johnson & Johnson (JNJ) Gains FDA Nod for TREMFYA Subcutaneous Therapy\n\n\n(Insider Monkey)",
      "link": "/news/181858/johnson-johnson-jnj-gains-fda-nod-for-tremfya-subcutaneous-therapy"
    },
    {
      "date": "2025-10-01",
      "time": "19:38",
      "title": "Analyst Report: Johnson & Johnson\n\n\n(Morningstar Research)",
      "link": "https://finance.yahoo.com/m/89bee878-6cb8-3401-be5d-2e6d35116cd9/analyst-report%3A-johnson-%26.html"
    },
    {
      "date": "2025-10-05",
      "time": "07:04PM",
      "title": "Chart Master: A breakout could signal more upside for beaten-down pharma stocks\n\n\n(CNBC TV)",
      "link": "https://www.youtube.com/watch?v=vU4IoqAQ91Q"
    },
    {
      "date": "2025-10-05",
      "time": "04:55PM",
      "title": "Drug Stock Rally Helps Push Dow and S&P 500 to Records\n\n\n(The Wall Street Journal)",
      "link": "https://www.wsj.com/finance/stocks/global-stocks-markets-dow-news-10-01-2025-bf78f02f?mod=wsj_FV"
    },
    {
      "date": "2025-10-05",
      "time": "11:11AM",
      "title": "Marla Beck Steps Down as CEO of Hydrafacial Owner\n\n\n(WWD)",
      "link": "https://finance.yahoo.com/m/5b488f1f-9a27-3a71-9bad-479acfdaf059/marla-beck-steps-down-as-ceo.html"
    },
    {
      "date": "2025-10-05",
      "time": "11:10AM",
      "title": "Headlines Boost Pharma Stocks. Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Speak to Rally Into Year End\n\n\n(Barrons.com)",
      "link": "https://www.barrons.com/articles/pfizer-johnson-johnson-jazz-pharmaceuticals-stocks-to-rally-into-year-end-25678097?mod=bar_FV"
    },
    {
      "date": "2025-10-05",
      "time": "10:13AM",
      "title": "ISRG Expands SP Indications: A Game Changer in Colorectal Surgery?\n\n\n(Zacks)",
      "link": "/news/181076/isrg-expands-sp-indications-a-game-changer-in-colorectal-surgery"
    },
    {
      "date": "2025-10-05",
      "time": "05:31AM",
      "title": "Bristol Myers, Takeda to pool data for AI-based drug discovery\n\n\n(Reuters)",
      "link": "https://finance.yahoo.com/news/bristol-myers-takeda-pool-data-093127023.html"
    },
    {
      "date": "2025-10-05",
      "time": "04:44AM",
      "title": "Should You Buy Kenvue Stock After Its 30% Plunge?\n\n\n(Motley Fool)",
      "link": "/news/180481/should-you-buy-kenvue-stock-after-its-30-plunge"
    },
    {
      "date": "2025-09-30",
      "time": "17:14",
      "title": "Pfizer Stock Surges After Company Makes a Deal With President Trump\n\n\n(The Wall Street Journal)",
      "link": "https://finance.yahoo.com/m/5d8a361e-7039-366b-a5d8-1723528a8ca2/pfizer-stock-surges-after.html"
    },
    {
      "date": "2025-10-05",
      "time": "04:38PM",
      "title": "Stocks Post Late Rally After Trump Strikes Deal With Pfizer\n\n\n(The Wall Street Journal)",
      "link": "https://finance.yahoo.com/m/476d95c0-1215-31ae-afe5-2ef5bcd30c79/stocks-post-late-rally-after.html"
    },
    {
      "date": "2025-10-05",
      "time": "02:04PM",
      "title": "Jim Cramer on Johnson & Johnson: \"It's Differentiating Itself From the Pack\"\n\n\n(Insider Monkey)",
      "link": "/news/179937/jim-cramer-on-johnson-johnson-its-differentiating-itself-from-the-pack"
    },
    {
      "date": "2025-10-05",
      "time": "07:35AM",
      "title": "J&J gets FDA approval for Tremfya in paediatric psoriasis\n\n\n(Pharmaceutical Technology)",
      "link": "https://finance.yahoo.com/m/e7872e9d-d374-39e6-8af7-496951e9975e/j%26j-gets-fda-approval-for.html"
    },
    {
      "date": "2025-10-05",
      "time": "06:30AM",
      "title": "Genmab Strikes $8 Billion Deal for Cancer Treatment Maker Merus\n\n\n(The Daily Upside)",
      "link": "https://finance.yahoo.com/m/e579b81d-fac2-3790-a105-b1cd8fff32d9/genmab-strikes-%248-billion.html"
    },
    {
      "date": "2025-10-05",
      "time": "04:00AM",
      "title": "Johnson & Johnson (JNJ) to Withdraw Acid Reflux Treatment in Some Markets\n\n\n(Insider Monkey)",
      "link": "/news/179050/johnson-johnson-jnj-to-withdraw-acid-reflux-treatment-in-some-markets"
    },
    {
      "date": "2025-09-29",
      "time": "16:25",
      "title": "Genmab Strikes $8 Billion Deal To Acquire Cancer-Focused Merus\n\n\n(Investor's Business Daily)",
      "link": "https://finance.yahoo.com/m/c1d15173-d4a8-35fc-837b-f3209297db37/genmab-strikes-%248-billion.html"
    },
    {
      "date": "2025-10-05",
      "time": "03:15PM",
      "title": "The AI Rally Is on Pause. Try These 11 Non-Tech Stocks.\n\n\n(Barrons.com)",
      "link": "https://www.barrons.com/articles/nontech-stocks-buy-ai-rally-77e4a953?mod=bar_FV"
    },
    {
      "date": "2025-10-05",
      "time": "01:37PM",
      "title": "Johnson & Johnson (JNJ): A Dividend Aristocrat With Unmatched Stability\n\n\n(Insider Monkey)",
      "link": "/news/178689/johnson-johnson-jnj-a-dividend-aristocrat-with-unmatched-stability"
    },
    {
      "date": "2025-10-05",
      "time": "08:00AM",
      "title": "U.S. FDA approves TREMFYA (guselkumab) for the treatment of pediatric plaque psoriasis and active psoriatic arthritis, marking a first and only approval for an IL-23 inhibitor\n\n\n(PR Newswire)",
      "link": "/news/178190/us-fda-approves-tremfya-guselkumab-for-the-treatment-of-pediatric-plaque-psoriasis-and-active-psoriatic-arthritis-marking-a-first-and-only-approval-for-an-il-23-inhibitor"
    },
    {
      "date": "2025-09-28",
      "time": "18:15",
      "title": "Why Johnson & Johnson Could Be the Ultimate Dividend King\n\n\n(Motley Fool)",
      "link": "/news/177773/why-johnson-johnson-could-be-the-ultimate-dividend-king"
    },
    {
      "date": "2025-09-27",
      "time": "10:44",
      "title": "Johnson & Johnson (JNJ) to Withdraw the LINC Reflux Management System from Markets Outside the U.S.\n\n\n(Insider Monkey)",
      "link": "/news/177554/johnson-johnson-jnj-to-withdraw-the-linc-reflux-management-system-from-markets-outside-the-us"
    },
    {
      "date": "2025-09-26",
      "time": "22:48",
      "title": "'I'm an optimist,' says Johnson & Johnson CEO on its R&D investment\n\n\n(CNBC TV)",
      "link": "https://www.youtube.com/watch?v=z4JLisTTzMQ"
    },
    {
      "date": "2025-10-05",
      "time": "08:48PM",
      "title": "Watch Jim Cramer's interview with Johnson & Johnson CEO Joaquin Duato\n\n\n(CNBC TV)",
      "link": "https://www.youtube.com/watch?v=vfC1xkmjAvU"
    },
    {
      "date": "2025-10-05",
      "time": "05:45PM",
      "title": "Johnson & Johnson (JNJ) Surpasses Market Returns: Some Facts Worth Knowing\n\n\n(Zacks)",
      "link": "/news/177351/johnson-johnson-jnj-surpasses-market-returns-some-facts-worth-knowing"
    },
    {
      "date": "2025-10-05",
      "time": "11:45AM",
      "title": "Has AbbVie Successfully Navigated Top-line Growth Post Humira LOE?\n\n\n(Zacks)",
      "link": "/news/177170/has-abbvie-successfully-navigated-top-line-growth-post-humira-loe"
    },
    {
      "date": "2025-10-05",
      "time": "09:58AM",
      "title": "Trump's new tariffs on pharma, furniture, & trucks: What to know\n\n\n(Yahoo Finance Video)",
      "link": "https://finance.yahoo.com/video/trumps-tariffs-pharma-furniture-trucks-135821259.html"
    },
    {
      "date": "2025-10-05",
      "time": "09:14AM",
      "title": "Big pharma stocks rise as Street reacts to latest presidential tariff plan\n\n\n(Associated Press Finance)",
      "link": "https://finance.yahoo.com/news/big-pharma-stocks-rise-street-131407155.html"
    },
    {
      "date": "2025-10-05",
      "time": "08:11AM",
      "title": "What to Expect From Johnson & Johnsons Q3 2025 Earnings Report\n\n\n(Barchart)",
      "link": "https://finance.yahoo.com/m/74a691b9-d630-3376-a527-9f41286c207d/what-to-expect-from-johnson-%26.html"
    },
    {
      "date": "2025-10-05",
      "time": "07:21AM",
      "title": "Could This Single Dividend King Make Your Portfolio Worth $1 Million in 20 Years?\n\n\n(Motley Fool)",
      "link": "/news/176646/could-this-single-dividend-king-make-your-portfolio-worth-1-million-in-20-years"
    },
    {
      "date": "2025-10-05",
      "time": "05:06AM",
      "title": "J&J: Still a Defensive Giant, or Too Dependent on Pharma?\n\n\n(GuruFocus.com)",
      "link": "https://finance.yahoo.com/news/j-j-still-defensive-giant-090617526.html"
    },
    {
      "date": "2025-10-05",
      "time": "04:41AM",
      "title": "Is pharmas IRA pricing battle running out of steam?\n\n\n(Pharma Voice)",
      "link": "https://finance.yahoo.com/m/6078ea05-af5a-33d7-914e-d21513e51871/is-pharma%E2%80%99s-ira-pricing.html"
    },
    {
      "date": "2025-10-05",
      "time": "03:17AM",
      "title": "Trump Plans New Tariff Push With 100% Rate on Patented Drugs\n\n\n(Bloomberg)",
      "link": "https://finance.yahoo.com/news/trump-plans-tariff-push-100-071715850.html"
    },
    {
      "date": "2025-09-25",
      "time": "16:15",
      "title": "Vicarious Surgical Announces Appointment of Joseph Doherty as Chairman of The Board\n\n\n(Business Wire)",
      "link": "https://www.businesswire.com/news/home/20250925904265/en/"
    },
    {
      "date": "2025-10-05",
      "time": "12:53PM",
      "title": "Will BDTX's EGFR Inhibitor Bring a Paradigm Shift in NSCLC Treatment?\n\n\n(Zacks)",
      "link": "/news/176106/will-bdtxs-egfr-inhibitor-bring-a-paradigm-shift-in-nsclc-treatment"
    },
    {
      "date": "2025-10-05",
      "time": "11:52AM",
      "title": "AstraZeneca Stock Rises 15% YTD: Should You Buy, Sell or Hold?\n\n\n(Zacks)",
      "link": "/news/176012/astrazeneca-stock-rises-15-ytd-should-you-buy-sell-or-hold"
    },
    {
      "date": "2025-10-05",
      "time": "11:45AM",
      "title": "Johnson & Johnson (JNJ) Could Be a Great Choice\n\n\n(Zacks)",
      "link": "/news/175981/johnson-johnson-jnj-could-be-a-great-choice"
    },
    {
      "date": "2025-10-05",
      "time": "09:55AM",
      "title": "Josh Brown Talks About Johnson & Johnson's (JNJ) Upcoming 'Big Catalyst'\n\n\n(Insider Monkey)",
      "link": "/news/175712/josh-brown-talks-about-johnson-johnsons-jnj-upcoming-big-catalyst"
    },
    {
      "date": "2025-10-05",
      "time": "09:00AM",
      "title": "Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know\n\n\n(Zacks)",
      "link": "/news/175716/investors-heavily-search-johnson-johnson-jnj-here-is-what-you-need-to-know"
    },
    {
      "date": "2025-10-05",
      "time": "04:52AM",
      "title": "These 3 Dow Stocks Are Set to Soar in 2025 and Beyond\n\n\n(Motley Fool)",
      "link": "/news/175359/these-3-dow-stocks-are-set-to-soar-in-2025-and-beyond"
    },
    {
      "date": "2025-10-05",
      "time": "03:15AM",
      "title": "3 Exceptional High-Yielding Dividend Kings That Have Been Increasing Their Payouts for Over 60 Years\n\n\n(Motley Fool)",
      "link": "/news/175295/3-exceptional-high-yielding-dividend-kings-that-have-been-increasing-their-payouts-for-over-60-years"
    },
    {
      "date": "2025-09-24",
      "time": "19:30",
      "title": "Why This Dividend King Still Stands Tall\n\n\n(Barchart)",
      "link": "https://finance.yahoo.com/m/23ccbfa5-1468-3d6e-9aa0-0e5ffc49e2b7/why-this-dividend-king-still.html"
    },
    {
      "date": "2025-10-05",
      "time": "01:12PM",
      "title": "As Trump Takes Aim at Tylenol, Should You Buy, Sell, or Hold Parent Company Kenvue Stocks Here?\n\n\n(Barchart)",
      "link": "https://finance.yahoo.com/m/bbe8bd5b-2da7-34b9-b030-935b6266bfd5/as-trump-takes-aim-at.html"
    },
    {
      "date": "2025-10-05",
      "time": "09:37AM",
      "title": "Tylenol Maker Kenvue Faces Mounting Crisis After Trump Blast\n\n\n(Bloomberg)",
      "link": "https://finance.yahoo.com/news/tylenol-maker-kenvue-faces-mounting-133725508.html"
    },
    {
      "date": "2025-10-05",
      "time": "09:30AM",
      "title": "Should You Invest in Johnson & Johnson (JNJ) Based on Bullish Wall Street Views?\n\n\n(Zacks)",
      "link": "/news/174670/should-you-invest-in-johnson-johnson-jnj-based-on-bullish-wall-street-views"
    },
    {
      "date": "2025-10-05",
      "time": "08:49AM",
      "title": "Robotics and MedSurg Drive Stryker Growth Amid Margin Pressures\n\n\n(Zacks)",
      "link": "/news/174584/robotics-and-medsurg-drive-stryker-growth-amid-margin-pressures"
    },
    {
      "date": "2025-10-05",
      "time": "08:00AM",
      "title": "Climate Week NYC 2025 commences with slate of disaster response, green infrastructure deals\n\n\n(ESG Dive)",
      "link": "https://finance.yahoo.com/m/a59bb26d-4319-3097-8ed1-1b5c7342634a/climate-week-nyc-2025.html"
    },
    {
      "date": "2025-10-05",
      "time": "05:25AM",
      "title": "Analyst Report: Johnson & Johnson\n\n\n(Morningstar Research)",
      "link": "https://finance.yahoo.com/m/ca20343f-87df-38a7-953c-6432107bd1a4/analyst-report%3A-johnson-%26.html"
    },
    {
      "date": "2025-09-23",
      "time": "23:41",
      "title": "J&Js Abiomed starts third heart pump controller recall since June\n\n\n(MedTech Dive)",
      "link": "https://finance.yahoo.com/m/8b64622c-7059-386e-9b92-50b78545e149/j%26j%E2%80%99s-abiomed-starts-third.html"
    },
    {
      "date": "2025-10-05",
      "time": "08:21PM",
      "title": "Johnson & Johnson Impresses with Earnings Beat, Dividend Hike, and Bullish Analyst Target\n\n\n(Insider Monkey)",
      "link": "/news/173953/johnson-johnson-impresses-with-earnings-beat-dividend-hike-and-bullish-analyst-target"
    },
    {
      "date": "2025-10-05",
      "time": "07:02PM",
      "title": "Johnson & Johnson (JNJ) Gains FDA Nod for Subcutaneous Tremfya in Ulcerative Colitis\n\n\n(Insider Monkey)",
      "link": "/news/173888/johnson-johnson-jnj-gains-fda-nod-for-subcutaneous-tremfya-in-ulcerative-colitis"
    },
    {
      "date": "2025-10-05",
      "time": "05:11PM",
      "title": "Analyst Report: Kenvue Inc.\n\n\n(Morningstar Research)",
      "link": "https://finance.yahoo.com/m/b834c364-7cf6-3cbe-b94a-084584ce3f9d/analyst-report%3A-kenvue-inc..html"
    },
    {
      "date": "2025-10-05",
      "time": "01:59PM",
      "title": "Kenvue stock rebounds as Trump's Tylenol claims face pushback\n\n\n(Reuters Videos)",
      "link": "https://finance.yahoo.com/video/kenvue-stock-rebounds-trumps-tylenol-175948648.html"
    },
    {
      "date": "2025-10-05",
      "time": "11:32AM",
      "title": "Tesla, Lululemon, Johnson & Johnson: Top analyst calls\n\n\n(Yahoo Finance Video)",
      "link": "https://finance.yahoo.com/video/tesla-lululemon-johnson-johnson-top-153225191.html"
    },
    {
      "date": "2025-10-05",
      "time": "09:40AM",
      "title": "CoreWeave upgraded, Lululemon downgraded: Wall Street's top analyst calls\n\n\n(The Fly)",
      "link": "https://finance.yahoo.com/news/coreweave-upgraded-lululemon-downgraded-wall-134046337.html"
    },
    {
      "date": "2025-10-05",
      "time": "09:06AM",
      "title": "J&Js push into new medicines to offset the Stelara loss, Guggenheim says\n\n\n(Investing.com)",
      "link": "https://finance.yahoo.com/news/j-j-push-medicines-offset-130619794.html"
    },
    {
      "date": "2025-10-05",
      "time": "07:49AM",
      "title": "Tylenol maker rebounds a day after Trump's unfounded claims about its safety\n\n\n(Associated Press Finance)",
      "link": "https://finance.yahoo.com/news/tylenol-maker-rebounds-day-trumps-114914267.html"
    },
    {
      "date": "2025-10-05",
      "time": "06:47AM",
      "title": "Nvidia Exposes a Stock Market Problem. How the Fed Can Solve It.\n\n\n(Barrons.com)",
      "link": "https://www.barrons.com/articles/nvidia-stock-market-fed-things-to-know-today-9cdccac0?mod=bar_FV"
    },
    {
      "date": "2025-10-05",
      "time": "06:30AM",
      "title": "Tylenol-Makers Shares Sink amid Autism Scrutiny\n\n\n(The Daily Upside)",
      "link": "https://finance.yahoo.com/m/18f17bb9-74be-3ccb-bc4a-c38c94c21a1f/tylenol-maker%E2%80%99s-shares-sink.html"
    },
    {
      "date": "2025-10-05",
      "time": "04:05AM",
      "title": "The Ultimate Dividend King Drug Stock to Buy With $1,000 Right Now\n\n\n(Motley Fool)",
      "link": "/news/172921/the-ultimate-dividend-king-drug-stock-to-buy-with-1000-right-now"
    },
    {
      "date": "2025-09-22",
      "time": "18:18",
      "title": "Kenvue Stock Hits All-Time Low, Turns Higher After-Hours\n\n\n(The Wall Street Journal)",
      "link": "https://finance.yahoo.com/m/af221604-afa5-33dd-be6e-325222b5dda6/kenvue-stock-hits-all-time.html"
    },
    {
      "date": "2025-10-05",
      "time": "05:15PM",
      "title": "Johnson & Johnson (JNJ) Announced the European launch of Its Shockwave Javelin Peripheral IVL Catheter\n\n\n(Insider Monkey)",
      "link": "/news/172688/johnson-johnson-jnj-announced-the-european-launch-of-its-shockwave-javelin-peripheral-ivl-catheter"
    },
    {
      "date": "2025-10-05",
      "time": "03:19PM",
      "title": "Kenvue Gets Crunched Again\n\n\n(The Wall Street Journal)",
      "link": "https://finance.yahoo.com/m/af221604-afa5-33dd-be6e-325222b5dda6/kenvue-gets-crunched-again.html"
    },
    {
      "date": "2025-10-05",
      "time": "03:19PM",
      "title": "Analyst Report: Kenvue Inc.\n\n\n(Morningstar Research)",
      "link": "https://finance.yahoo.com/m/b44f5d3c-e172-3906-935f-4e175a116b79/analyst-report%3A-kenvue-inc..html"
    },
    {
      "date": "2025-10-05",
      "time": "02:58PM",
      "title": "Tylenol-maker Kenvues stock has lost a quarter of its value in 6 months as momentum grows for autism link despite repeated denials\n\n\n(Fortune)",
      "link": "https://finance.yahoo.com/news/tylenol-maker-kenvue-stock-lost-185855115.html"
    },
    {
      "date": "2025-10-05",
      "time": "02:05PM",
      "title": "What is Kenvue? The Tylenol maker facing RFK Jr. scrutiny over autism claims\n\n\n(USA TODAY)",
      "link": "https://finance.yahoo.com/m/d717ddfd-bbe6-33bf-901c-20a51bb503ee/what-is-kenvue%3F-the-tylenol.html"
    },
    {
      "date": "2025-10-05",
      "time": "09:16AM",
      "title": "J&J Adds $63B in Market Cap in 3 Months: Time to Buy the Stock?\n\n\n(Zacks)",
      "link": "/news/172287/jj-adds-63b-in-market-cap-in-3-months-time-to-buy-the-stock"
    },
    {
      "date": "2025-10-05",
      "time": "09:09AM",
      "title": "Take the Zacks Approach to Beat the Market: LendingTree, AutoZone, J&J in Focus\n\n\n(Zacks)",
      "link": "/news/172254/take-the-zacks-approach-to-beat-the-market-lendingtree-autozone-jj-in-focus"
    },
    {
      "date": "2025-09-21",
      "time": "04:44",
      "title": "Could These 3 Dividend Kings Be Worth $1 Trillion in 10 Years?\n\n\n(Motley Fool)",
      "link": "/news/171594/could-these-3-dividend-kings-be-worth-1-trillion-in-10-years"
    },
    {
      "date": "2025-09-20",
      "time": "23:25",
      "title": "Johnson & Johnson's (JNJ) Dividend Growth Record Strengthens its Role in Dividend Paying Stocks\n\n\n(Insider Monkey)",
      "link": "/news/171507/johnson-johnsons-jnj-dividend-growth-record-strengthens-its-role-in-dividend-paying-stocks"
    },
    {
      "date": "2025-10-05",
      "time": "04:46AM",
      "title": "What Is Considered a Good Stock Dividend? 3 Healthcare Stocks That Fit the Bill\n\n\n(Motley Fool)",
      "link": "/news/171380/what-is-considered-a-good-stock-dividend-3-healthcare-stocks-that-fit-the-bill"
    },
    {
      "date": "2025-09-19",
      "time": "17:28",
      "title": "TREMFYA (guselkumab) achieves U.S. approval for subcutaneous induction in adults with ulcerative colitis, now the first and only IL-23 inhibitor with a fully subcutaneous regimen\n\n\n(PR Newswire)",
      "link": "/news/171210/tremfya-guselkumab-achieves-us-approval-for-subcutaneous-induction-in-adults-with-ulcerative-colitis-now-the-first-and-only-il-23-inhibitor-with-a-fully-subcutaneous-regimen"
    },
    {
      "date": "2025-10-05",
      "time": "01:17PM",
      "title": "Can Regeneron Change The Paradigm In Multiple Myeloma - And Undercut J&J?\n\n\n(Investor's Business Daily)",
      "link": "https://www.investors.com/news/technology/regeneron-smoldering-multiple-myeloma-johnson-johnson-darzalex?mod=IBD_FV"
    },
    {
      "date": "2025-10-05",
      "time": "12:06PM",
      "title": "J&Js newly diagnosed multiple myeloma induction combo elicits 100% OR\n\n\n(Clinical Trials Arena)",
      "link": "https://finance.yahoo.com/m/7cdf87ee-9ed7-30e3-84e1-52f788df2a92/j%26j%E2%80%99s-newly-diagnosed.html"
    },
    {
      "date": "2025-10-05",
      "time": "12:03PM",
      "title": "Boost Your Portfolio With These Top-Ranked ETFs\n\n\n(Zacks)",
      "link": "/news/171005/boost-your-portfolio-with-these-top-ranked-etfs"
    },
    {
      "date": "2025-10-05",
      "time": "11:53AM",
      "title": "Can MRK's New Drugs Drive Long-Term Growth Amid Looming Keytruda LOE?\n\n\n(Zacks)",
      "link": "/news/170978/can-mrks-new-drugs-drive-long-term-growth-amid-looming-keytruda-loe"
    },
    {
      "date": "2025-10-05",
      "time": "08:30AM",
      "title": "TECVAYLI and DARZALEX FASPRO-based induction treatment demonstrates promising rates and depths of response in transplant-eligible patients with newly diagnosed multiple myeloma\n\n\n(PR Newswire)",
      "link": "/news/170559/tecvayli-and-darzalex-faspro-based-induction-treatment-demonstrates-promising-rates-and-depths-of-response-in-transplant-eligible-patients-with-newly-diagnosed-multiple-myeloma"
    },
    {
      "date": "2025-10-05",
      "time": "07:07AM",
      "title": "Top Wide-Moat Stocks Worth a Look for Sustainable Growth\n\n\n(Zacks)",
      "link": "/news/170542/top-wide-moat-stocks-worth-a-look-for-sustainable-growth"
    },
    {
      "date": "2025-10-05",
      "time": "05:45AM",
      "title": "8 Dividend Growth Stocks Every Investor Should Consider\n\n\n(Motley Fool)",
      "link": "/news/170376/8-dividend-growth-stocks-every-investor-should-consider"
    },
    {
      "date": "2025-10-05",
      "time": "04:39AM",
      "title": "J&Js IVL market dominance to continue with launch of Javelin catheter in Europe\n\n\n(Medical Device Network)",
      "link": "https://finance.yahoo.com/m/16b83e31-9cbf-36b0-a526-da99f65e87f2/j%26j%E2%80%99s-ivl-market-dominance-to.html"
    },
    {
      "date": "2025-09-18",
      "time": "23:26",
      "title": "Jim Cramer on Johnson & Johnson: \"Very Rare Triple-A Balance Sheet\"\n\n\n(Insider Monkey)",
      "link": "/news/170199/jim-cramer-on-johnson-johnson-very-rare-triple-a-balance-sheet"
    },
    {
      "date": "2025-10-05",
      "time": "05:45PM",
      "title": "Johnson & Johnson (JNJ) Stock Dips While Market Gains: Key Facts\n\n\n(Zacks)",
      "link": "/news/170128/johnson-johnson-jnj-stock-dips-while-market-gains-key-facts"
    },
    {
      "date": "2025-10-05",
      "time": "11:30AM",
      "title": "J&J Expects Innovative Medicines Growth Despite Stelara LOE: Here's Why\n\n\n(Zacks)",
      "link": "/news/169846/jj-expects-innovative-medicines-growth-despite-stelara-loe-heres-why"
    },
    {
      "date": "2025-10-05",
      "time": "07:37AM",
      "title": "J&J and Protagonists oral plaque psoriasis drug bests BMS Sotyktu\n\n\n(Clinical Trials Arena)",
      "link": "https://finance.yahoo.com/m/b2288e24-0e9d-332b-942b-d364356a5a9e/j%26j-and-protagonist%E2%80%99s-oral.html"
    },
    {
      "date": "2025-10-05",
      "time": "07:13AM",
      "title": "J&J launches IVL device in Europe; Medtronic looks at pacing for more patients\n\n\n(MedTech Dive)",
      "link": "https://finance.yahoo.com/m/885884fd-1e88-3732-a803-31608bfb33ee/j%26j-launches-ivl-device-in.html"
    },
    {
      "date": "2025-09-17",
      "time": "11:56",
      "title": "GSK to Invest $30B in U.S. R&D and Manufacturing Over 5 Years\n\n\n(Zacks)",
      "link": "/news/168720/gsk-to-invest-30b-in-us-rd-and-manufacturing-over-5-years"
    },
    {
      "date": "2025-10-05",
      "time": "11:22AM",
      "title": "LLY's $5B Virginia Plant Plan: Will U.S. Manufacturing Shift Pay Off?\n\n\n(Zacks)",
      "link": "/news/168662/llys-5b-virginia-plant-plan-will-us-manufacturing-shift-pay-off"
    },
    {
      "date": "2025-10-05",
      "time": "08:00AM",
      "title": "Icotrokinra shows superiority to deucravacitinib in first reported head-to-head trials reinforcing promise of novel targeted oral peptide for treatment of plaque psoriasis\n\n\n(PR Newswire)",
      "link": "/news/168265/icotrokinra-shows-superiority-to-deucravacitinib-in-first-reported-head-to-head-trials-reinforcing-promise-of-novel-targeted-oral-peptide-for-treatment-of-plaque-psoriasis"
    }
  ]
}